NXgenPort (NGP), has designed an innovative and transformative technology to maximize remote care in cancer patients requiring an implantable chemo-port catheter. Combining proven chemo-port efficacy with microchip and sensor technology, NGP measures, monitors and reports physiological body functions in vivo over the course of disease and treatment.
In this episode, Founder and CEO Kathy Skinner shares the details of how this port advances care for a very important patient population and how its quickly gaining momentum.
Embrace Prevention Care provides Personal Prevention Care to older adults with heart failure and other chronic conditions to help them take healthy actions that...
PathKeeper is an innovative robotic company founded in Israel.The company's disruptive, proprietary technology provides laser-like accuracy for spinal procedures. The unique technology tracks the...
Kimberly Hutchison, MD is a neurologist who specializes in Sleep Medicine. While there is expectation that someday the CPAP will be replaced as a...
